Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 9—September 2020

Sequence Type Changes Associated with Decreasing Macrolide-Resistant Mycoplasma pneumoniae, Japan

Miyuki Morozumi, Takeshi Tajima, Megumi Sakuma, Michi Shouji, Hidenori Meguro, Kota Saito, Satoshi Iwata, and Kimiko UbukataComments to Author 
Author affiliations: Keio University School of Medicine, Tokyo, Japan (M. Morozumi, M. Sakuma, S. Iwata, K. Ubukata); Hakujikai Memorial Hospital, Tokyo (T. Tajima); National Center for Global Health and Medicine, Tokyo (M. Shouji); Meguro Clinic, Chiba, Japan (H. Meguro); Saito Pediatric Clinic, Saitama, Japan (K. Saito); National Cancer Center Hospital, Tokyo (S. Iwata)

Main Article


Yearly changes in macrolide-susceptible and macrolide-resistant Mycoplasma pneumoniae, Japan, 2002–2019*

Macrolide susceptibility† 2002–2005 2006–2009 2010–2013 2015–2016 2018–2019 Total
Susceptible 241 (93.1) 161 (62.6) 45 (13.8) 86 (43.7) 47 (88.7) 580
Resistant 18 (6.9) 96 (37.4) 281 (86.2) 111 (56.3) 6 (11.3) 512
Total 259 257 326 197 53 1,092

*Values are no. (%).
†Macrolide susceptibility was distinguished on the basis of a mutation in the 23S rRNA gene and results of susceptibility measurements.

Main Article

Page created: June 09, 2020
Page updated: August 19, 2020
Page reviewed: August 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.